Belgium faces a critical challenge in managing chronic obstructive pulmonary disease (COPD), ranking 31st out of 34 countries in a global index compiled by the Copenhagen Institute for Future Studies.
The nation lags significantly behind its neighbors France (9th), the Netherlands (18th), and Germany (28th), as well as other global leaders like Australia, the United Kingdom, and Finland.
The report underscores serious deficiencies in Belgium’s approach to managing COPD, a condition characterized by inflammation of the airways, which leads to lung damage and progressive breathing difficulties.
Smoking is the primary cause of COPD, with approximately nine out of ten patients in Belgium being current or former smokers.
A Silent Epidemic
According to the Belgian Lung Foundation (BeLF), more than 800,000 people in the country suffer from COPD. Alarmingly, half of these individuals are unaware of their condition, leading to delays in diagnosis and treatment.
COPD accounts for 5% of all deaths in Belgium and is the third leading cause of death after cardiovascular diseases and cancer.
Globally, the disease burden of COPD is immense, but Belgium’s position in the rankings highlights specific shortcomings.
The Danish institute’s findings point to late diagnoses as a key issue, compounded by a lack of cooperation among healthcare providers, limited public awareness, and insufficient epidemiological data.
Belgium Trails Europe in COPD Care
Belgium’s poor performance is particularly striking when compared to its European peers. While France and the Netherlands have established robust public health frameworks to address COPD, Belgium has been slower to implement similar strategies.
Only Lithuania ranks lower in Europe, with non-European nations like China and India also trailing significantly.
The report’s findings suggest that systemic weaknesses in Belgium’s healthcare system hinder its ability to address COPD effectively. Key challenges include inadequate access to diagnostic tools, particularly spirometry tests, which are crucial for early detection.
Urgent Calls for Action
In response to the alarming statistics, the Belgian Lung Foundation has outlined a four-point plan to address the crisis:
- Raising Awareness: Public campaigns are needed to educate citizens about the risks of COPD and the importance of early detection.
- Improved Diagnosis: Widespread use of spirometry, a simple and non-invasive test, could significantly enhance early identification of the disease.
- Focus on Prevention: Strengthening anti-smoking initiatives and promoting healthier lifestyles could help reduce the incidence of COPD.
- Optimised Treatment: Enhanced collaboration among healthcare providers and improved access to treatment options are essential for better disease management.
A National Wake-Up Call
Experts warn that without immediate action, the burden of COPD in Belgium will continue to rise. “Belgium’s ranking is a wake-up call for the entire healthcare system,” said a spokesperson for BeLF. “We must prioritise this issue and implement comprehensive measures to improve patient outcomes.”
COPD is preventable and manageable if detected early, making the current gaps in Belgium’s approach all the more concerning.
The Danish report and BeLF’s recommendations have sparked discussions among policymakers, healthcare providers, and advocacy groups about the need for urgent reform.
Whether Belgium can reverse its trajectory and improve its standing in COPD care will depend on how quickly it acts to address the root causes of its poor performance.
, Netherlands (18th), and Germany (28th), as well as Australia, the United Kingdom, and Finland){kind=link}